The classical mechanisms of HSP70 and gp96 against tumors are believed that they may act as chaperones to facilitate major histocompatibility complex-1 (MHC-I) peptide loading, therefore increasing the tumor peptides presented by MHC-I [37–39]. Here, HSP90B1 is linked to neoplasm.